REGISTERED
on 15 Sep 2020
Last Applicant/ Owned by
1 DNA WAY
SOUTH SAN FRANCISCO
CA
940804990
Serial Number
88606375 filed on 05th Sep 2019
Registration Number
6151018 registered on 15th Sep 2020
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
THIOMAB
Antibody technology platform used to incorporate cysteines into an antibody, namely, protein arrays and nucleotide arrays for scientific and medical research Antibody technology platform used to incorporate cysteines into an antibody, namely, protein arrays for medical diagnosis purposes
Classification Information
Class [005]
Pharmaceutical Products
Antibody technology platform used to incorporate cysteines into an antibody, namely, protein arrays for medical diagnosis purposes
First Use Date in General
26th Aug 2019
First Use Date in Commerce
26th Aug 2019
Class [001]
Chemical Products
Antibody technology platform used to incorporate cysteines into an antibody, namely, protein arrays and nucleotide arrays for scientific and medical research
First Use Date in General
26th Aug 2019
First Use Date in Commerce
26th Aug 2019
Mark Details
Serial Number
No 88606375
Mark Type
No Service/Collective Mark
Attorney Docket Number
No TM-12532-US5
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 03rd May 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| 03rd May 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 03rd May 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 03rd May 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 11th Aug 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 11th Aug 2021 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| 11th Aug 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 11th Aug 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 19th Apr 2021 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 19th Apr 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |